Imidazoquinoxaline protein tyrosine kinase inhibitors

US6235740A · kind A · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Joel C. Barrish · Richboro, US
• Ping Chen · San Diego, US
• Jagabandhu Das · Mercerville, US
• Edwin J. Iwanowicz · Cranbury, US
• Derek J. Norris · Pennington, US
• Ramesh Padmanabha · Hamden, US
• Jacques Y. Roberge · Princeton, US
• Gary L. Schieven · Seattle, US

Key dates

• Filing date: Jun 15, 1998
• Grant date: May 22, 2001
• Expiry date: Jun 15, 2018

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D491/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel imidazoquinoxalines and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic disorders.